Alendronic acid and Paroxysmal supraventricular tachycardia - a phase IV clinical study of FDA data
We study 16,291 people who have side effects when taking Alendronic acid. Paroxysmal supraventricular tachycardia is found, especially among people who are female, 60+ old, also take Paracetamol and have Schizophrenia.
The phase IV clinical study analyzes which people take Alendronic acid and have Paroxysmal supraventricular tachycardia. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
16,291 people reported to have side effects when taking Alendronic acid.
Among them, 13 people (0.08%) have Paroxysmal supraventricular tachycardia.
What is Alendronic acid?
Alendronic acid has active ingredients of alendronate sodium. It is used in osteoporosis. Currently, eHealthMe is studying from 16,551 Alendronic acid users.
What is Paroxysmal supraventricular tachycardia?
Paroxysmal supraventricular tachycardia is found to be associated with 2,189 drugs and 1,793 conditions by eHealthMe. Currently, we are studying 16,641 people who have Paroxysmal supraventricular tachycardia.
Number of Alendronic acid and Paroxysmal supraventricular tachycardia reports submitted per year:
Gender of people who have Paroxysmal supraventricular tachycardia when taking Alendronic acid *:
- female: 69.23 %
- male: 30.77 %
Age of people who have Paroxysmal supraventricular tachycardia when taking Alendronic acid *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 50 %
- 60+: 50 %
Common drugs people take besides Alendronic acid *:
- Paracetamol: 10 people, 76.92%
- Melatonin: 6 people, 46.15%
- Sertraline: 4 people, 30.77%
- Omeprazole: 4 people, 30.77%
- Simvastatin: 3 people, 23.08%
- Ondansetron: 3 people, 23.08%
- Chloramphenicol: 3 people, 23.08%
- Amlodipine: 2 people, 15.38%
- Aspirin: 2 people, 15.38%
- Hydroxyzine: 2 people, 15.38%
Common side effects people have besides Paroxysmal supraventricular tachycardia *:
- Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 7.69%
- Pulmonary Granuloma (tiny lump of inflamed tissue in the lungs): 1 person, 7.69%
- Lacunar Infarction (type of stroke): 1 person, 7.69%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 7.69%
- Fall: 1 person, 7.69%
- Cellulitis (infection under the skin): 1 person, 7.69%
- Cardiac Flutter (abnormal heart rhythm): 1 person, 7.69%
- Bifascicular Block (conduction abnormality in the heart where two of the three main fascicles of the his/purkinje system are blocked): 1 person, 7.69%
Common conditions people have *:
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 46.15%
- Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 23.08%
- Neuralgia (pain in one or more nerves): 2 people, 15.38%
- Pain: 1 person, 7.69%
- Breast Cancer Metastatic: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Alendronic acid and have Paroxysmal supraventricular tachycardia?Check whether Paroxysmal supraventricular tachycardia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Stuckey BG, Sallie R, "Alendronate-induced unmasking or deterioration of coeliac disease: a case series", Osteoporosis International, 2015 Jan .
- Lee WY, Sun LM, Lin MC, Liang JA, Chang SN, Sung FC, Muo CH, Kao CH, "A higher dosage of oral alendronate will increase the subsequent cancer risk of osteoporosis patients in Taiwan: a population-based cohort study", PloS one, 2012 Dec .
Alendronic acid side effects by duration, gender and age:
- Alendronic acid side effects (16,551 reports)
Paroxysmal supraventricular tachycardia treatments and more:
- Paroxysmal supraventricular tachycardia (16,641 reports)
Common drugs associated with Paroxysmal supraventricular tachycardia:
- Aspirin: 915 reports
- Prednisone: 653 reports
- Omeprazole: 528 reports
- Digoxin: 500 reports
- Furosemide: 478 reports
- Lasix: 468 reports
- Metformin: 430 reports
- Lisinopril: 407 reports
- Vioxx: 380 reports
- Amlodipine: 365 reports
All the drugs that are associated with Paroxysmal supraventricular tachycardia:
- Paroxysmal supraventricular tachycardia (2,189 drugs)
Common conditions associated with Paroxysmal supraventricular tachycardia:
- High blood pressure: 570 reports
- Diabetes: 369 reports
- Osteoporosis: 363 reports
- Rheumatoid arthritis: 355 reports
- Pain: 339 reports
- Primary pulmonary hypertension: 332 reports
All the conditions that are associated with Paroxysmal supraventricular tachycardia:
- Paroxysmal supraventricular tachycardia (1,793 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on alendronate sodium (the active ingredients of Alendronic acid) and Alendronic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Mometasone Furoate and Buscopan drug interaction - 16 seconds ago
- Garlic and Solu-Medrol drug interaction - 30 seconds ago
- Clozaril and Troponin I Increased - 39 seconds ago
- Codeine and Versed drug interaction - 48 seconds ago
- Rubraca and Glipizide drug interaction - a minute ago
- Nucala and Celiac Disease - Sprue - a minute ago
- Bisacodyl and Bextra drug interaction - a minute ago
- Erbitux and Prednisolone drug interaction - a minute ago
- Ibuprofen and Oxytrol For Women drug interaction - a minute ago
- Matulane and Taxotere drug interaction - a minute ago